Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
GBS Inc. GBS
$0.47
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
433577.00000000
-
week52high
2.89
-
week52low
0.36
-
Revenue
437146
-
P/E TTM
-6
-
Beta
0.00000000
-
EPS
-0.50200000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 авг 2022 г. в 04:00
Описание компании
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumour markers, hormones, and nucleic acid diagnostic modalities. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sakiris Spiro Kevin | A | 125228 | 75000 | 10 окт 2022 г. |
| Boyages Steven Constantine | A | 75000 | 75000 | 10 окт 2022 г. |
| FISHER LAWRENCE B | A | 15000 | 15000 | 10 окт 2022 г. |
| Margelis George | A | 15000 | 15000 | 10 окт 2022 г. |
| TOWERS CHRISTOPHER | A | 15800 | 15000 | 10 окт 2022 г. |
| Hurd Jonathan Scott | A | 15000 | 15000 | 10 окт 2022 г. |
| Simeonidis Harry | A | 80600 | 80000 | 10 окт 2022 г. |
| Sakiris Spiro Kevin | A | 50228 | 5000 | 22 июн 2022 г. |
| Sakiris Spiro Kevin | A | 45228 | 15970 | 17 июн 2022 г. |
| Life Science Biosensor Diagnostics Pty Ltd | D | 1081804 | 576028 | 17 февр 2022 г. |
Новостная лента
GBS, Inc. (GBS) Q4 2022 Earnings Call Transcript
Seeking Alpha
01 сент 2022 г. в 18:40
GBS, Inc. (NASDAQ:GBS ) Q4 2022 Earnings Conference Call August 31, 2022 4:30 PM ET Company Participants Steven Boyages - Chairman and Interim CEO Spiro Sakiris - CFO Conference Call Participants John Vandermosten - Zacks SCR Operator Greetings, and thank you for joining us for GBS, Inc's Fourth Quarter and Fiscal Yearend 2022 Financial and Business Update Conference Call. Currently all participants are in a listen-only mode.
GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31
GlobeNewsWire
29 авг 2022 г. в 09:05
Company to Host Conference Call & Webcast at 4:30 p.m. ET Company to Host Conference Call & Webcast at 4:30 p.m. ET